Cargando…
Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome
Cutaneous T-cell lymphoma is a group of incurable extranodal non-Hodgkin lymphomas that develop from the skin-homing CD4(+) T cell. Mycosis fungoides and Sézary syndrome are the most common histological subtypes. Although next-generation sequencing data provided significant advances in the comprehen...
Autores principales: | Caprini, Elisabetta, Bresin, Antonella, Cristofoletti, Cristina, Helmer Citterich, Mauro, Tocco, Valeria, Scala, Enrico, Monopoli, Alessandro, Benucci, Roberto, Narducci, Maria Grazia, Russo, Giandomenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281581/ https://www.ncbi.nlm.nih.gov/pubmed/30518749 http://dx.doi.org/10.1038/s41419-018-1212-7 |
Ejemplares similares
-
Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance
por: Cristofoletti, Cristina, et al.
Publicado: (2018) -
Combined High-Throughput Approaches Reveal the Signals Driven by Skin and Blood Environments and Define the Tumor Heterogeneity in Sézary Syndrome
por: Cristofoletti, Cristina, et al.
Publicado: (2022) -
T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1
por: Bresin, Antonella, et al.
Publicado: (2018) -
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome
por: Narducci, M G, et al.
Publicado: (2011) -
Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab
por: Narducci, Maria Grazia, et al.
Publicado: (2020)